Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 7, 2013 Metabolix Inc (NASDAQ:MBLX), Down By 8.54% ($0.21) From $2.460 After BUYINS.NET Report Predicted Weakness After Earnings
March 7, 2013 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Tuesday, March 5th 2013 stating that Metabolix Inc (NASDAQ:MBLX) was expected to be Down After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=mblx&id=352005
At the time this story was written, Metabolix Inc (NASDAQ:MBLX) is Down By 8.54% ($0.21) From $2.460 since the BUYINS.NET report was released.
The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php
Metabolix Inc (NASDAQ:MBLX) - Metabolix, Inc., a bioscience company, develops and commercializes technologies for the production of polymers and chemicals in plants and in microbes in the United States. It produces a family of biopolymers known as polyhydroxyalkanoates (PHAs), which occur naturally in living organisms and are chemically similar to polyesters. The company offers its biopolymers under the Mirel and Mvera brand names, and are used in agriculture/horticulture, compost and organic waste diversion, marine/aquatic, sustainable packaging, and consumer goods applications. It also develops four-carbon chemicals for high-performance engineering plastics and spandex applications; and three-carbon chemicals that have applications in paints, coatings, diapers, and adhesives. In addition, the company develops crops platform, a biorefinery system that uses plant crops to co-produce PHAs. It focuses to develop camelina for co-production of bioplastics along with vegetable oil, biodiesel fuel, and oleochemicals; to maximize bioplastic production in the leaf tissue of sugarcane; and to engineer switchgrass to produce bioplastics in the leaf and stem of the plant. The company serves primarily plastics, chemicals, and energy industries. Metabolix, Inc. was founded in 1992 and is based in Cambridge, Massachusetts..
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.
INVESTMENTS & TRADING
SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.
GATS -- tracks and quantifies known trading strategies.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Metabolix Inc (NASDAQ:MBLX) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net
- WOPRAI
- support@woprai.com